Yosuke Dotsu

High ratio of T790M to EGFR activating mutations correlate with the osimertinib response in non-small-cell lung cancer

Ryo Ariyasu, Shingo Nishikawa, Ken Uchibori et al. · Lung Cancer · 2018 · 53 citations

Medicine, Oncology, Pharmacology +17

Adrenal Insufficiency Related to Anti-Programmed Death-1 Therapy

Ryo Ariyasu, Atsushi Horiike, Takahiro Yoshizawa et al. · Anticancer Research · 2017 · 50 citations · Full text

Medicine, Endocrinology, Internal Medicine +16

Alert Regarding Cisplatin-induced Severe Adverse Events in Cancer Patients with Xeroderma Pigmentosum

Makoto Sumiyoshi, Hiroshi Soda, Noriaki Sadanaga et al. · Internal Medicine · 2017 · 24 citations · Full text

Pharmacy, Oncology, Toxicology +17

Correlation between thyroid transcription factor-1 expression, immune-related thyroid dysfunction, and efficacy of anti-programmed cell death protein-1 treatment in non-small cell lung cancer

Junji Koyama, Atsushi Horiike, Takahiro Yoshizawa et al. · Journal of Thoracic Disease · 2019 · 24 citations · Full text

Life Sciences, Immunology, Oncology +16

Remarkable response to pembrolizumab with <scp>platinum‐doublet</scp> in <scp>PD‐L1‐low</scp> pulmonary sarcomatoid carcinoma: A case report

Hirokazu Taniguchi, Shinnosuke Takemoto, Mutsumi Ozasa et al. · Thoracic Cancer · 2021 · 14 citations · Full text

Medicine, Oncology, Pharmacology +17